Agile Therapeutics, Inc.
AGRX · NASDAQ
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Market Cap | $4,206 | $4,906 | $1,184 | $243,037 |
| - Cash | $2,557 | $5,246 | $19,143 | $14,463 |
| + Debt | $2,172 | $2,211 | $17,792 | $16,519 |
| Enterprise Value | $3,821 | $1,871 | -$167 | $245,093 |
| Revenue | $19,593 | $10,884 | $4,101 | $749 |
| % Growth | 80% | 165.4% | 447.5% | – |
| Gross Profit | $10,615 | $4,048 | -$6,617 | $467 |
| % Margin | 54.2% | 37.2% | -161.4% | 62.3% |
| EBITDA | -$12,660 | -$25,422 | -$64,930 | -$48,468 |
| % Margin | -64.6% | -233.6% | -1,583.3% | -6,471% |
| Net Income | -$14,465 | -$25,412 | -$76,585 | -$54,686 |
| % Margin | -73.8% | -233.5% | -1,867.5% | -7,301.2% |
| EPS Diluted | -6.71 | -58.79 | -63,115.49 | -1,291.56 |
| % Growth | 88.6% | 99.9% | -4,786.8% | – |
| Operating Cash Flow | -$9,577 | -$35,947 | -$65,202 | -$47,311 |
| Capital Expenditures | $0 | -$133 | -$269 | -$353 |
| Free Cash Flow | -$9,577 | -$36,080 | -$65,471 | -$47,664 |